GLP-1s for Employers: Navigating What’s Next

This week on The Granite List.Live, Sally is joined by Jessica Lea, PharmD and CEO of Tria Health, as they dive into the fast-changing landscape of GLP-1 medications for obesity and diabetes. Jessica shares her insight on why pharmacist-led oversight is important, especially with complex and costly drugs like Ozempic and Wegovy. Additionally, together, Sally and Jessica explore:

• Challenges employers face when deciding whether to cover these medications
• The impact of direct-to-consumer options
• The importance of combining medication with lifestyle changes for lasting results
• Future developments in GLP-1 treatments and their potential uses.

Learn more about Tria Health on The Granite List!